Your Location：
Home >
Browse articles >
Scalable bioreactor manufacturing of iPSC-derived megakaryocytes with Proanthocyanidin A supplementation: a strategic platform for military blood supply resilience
LETTER TO THE EDITOR | Updated：2026-09-09
Previous|Next

    • Scalable bioreactor manufacturing of iPSC-derived megakaryocytes with Proanthocyanidin A supplementation: a strategic platform for military blood supply resilience

    • “Expert team established the quantum error correction system, verifying surface code stability under noise, which lays a foundation for the construction of large-scale quantum computing systems.”
    • Rabea Dettmer , Alice Rovai , Willem Wolkers , Rainer Blasczyk , Constanca Figueiredo
    • Military Medical Research (2026)

    • DOI： 10.1016/j.mmr.2026.100057     

      CLC：

    • Accepted：23 July 2026 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

27

Views

7

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Engineering of functional auditory neurons from human induced pluripotent stem cells
Frostbite: diagnosis, treatment, prognosis, and future directions
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Related Author

No data

Related Institution

No data